BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 2484309)

  • 1. Patterns of antigen expression in hepatoblastoma and hepatocellular carcinoma in childhood.
    O'Brien WJ; Finlay JL; Gilbert-Barness EF
    Pediatr Hematol Oncol; 1989; 6(4):361-5. PubMed ID: 2484309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemistry of hepatocellular carcinoma associated with cirrhosis.
    Espinoza CG; Pillarisetti SG; Azar HA
    Ann Clin Lab Sci; 1984; 14(6):467-73. PubMed ID: 6210034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The significance of alpha-fetoprotein and other tumour markers in differential immunocytochemistry of primary liver tumours.
    Brumm C; Schulze C; Charels K; Morohoshi T; Klöppel G
    Histopathology; 1989 May; 14(5):503-13. PubMed ID: 2472345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antigenic markers of hepatocellular carcinoma.
    Chedid A; Chejfec G; Eichorst M; Villamil F; Terg R; Telenta M; Hojman R
    Cancer; 1990 Jan; 65(1):84-7. PubMed ID: 1688400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distribution of alpha-fetoprotein and immunoreactive carcinoembryonic antigen in human hepatocellular carcinoma and hepatoblastoma.
    Hirohashi S; Shimosato Y; Ino Y; Kishi K; Ohkura H; Mukojima T
    Jpn J Clin Oncol; 1983 Mar; 13(1):37-43. PubMed ID: 6187946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distribution of five antigens in hepatocellular carcinoma.
    Thung SN; Gerber MA; Sarno E; Popper H
    Lab Invest; 1979 Aug; 41(2):101-5. PubMed ID: 88543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis B surface antigen and alpha-1-fetoprotein in hepatoma. Reports of 157 cases.
    Pongpipat D; Suvatte V; Plengvanit U; Chinapak O; Bunyaphisit S; Assateerawatts A
    J Med Assoc Thai; 1983 Nov; 66(11):696-9. PubMed ID: 6200559
    [No Abstract]   [Full Text] [Related]  

  • 8. The evaluation of tumour marker proteins in the diagnosis of primary hepatocellular carcinoma.
    Oon CJ; Yo SL; Chio LF; Chua D; Tan YO
    Ann Acad Med Singap; 1980 Apr; 9(2):228-33. PubMed ID: 6158907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroendocrine differentiation in hepatoblastoma. An immunohistochemical investigation.
    Ruck P; Harms D; Kaiserling E
    Am J Surg Pathol; 1990 Sep; 14(9):847-55. PubMed ID: 2167615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary malignant hepatic tumours in childhood.
    Schmidt D; Harms D; Lang W
    Virchows Arch A Pathol Anat Histopathol; 1985; 407(4):387-405. PubMed ID: 2413614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tissue antigen distribution in hepatocellular carcinoma.
    Busachi CA; Ferrari S; Ballardini PL; Landi P; Bazzocchi F; Santini D; Martinelli G; Piccaluga A; Pisi E
    Tumori; 1986 Feb; 72(1):1-5. PubMed ID: 2420048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunocytochemical evaluation of human esophageal neoplasms and preneoplastic lesions for beta-chorionic gonadotropin, placental lactogen, alpha-fetoprotein, carcinoembryonic antigen, and nonspecific cross-reacting antigen.
    Burg-Kurland CL; Purnell DM; Combs JW; Hillman EA; Harris CC; Trump BF
    Cancer Res; 1986 Jun; 46(6):2936-43. PubMed ID: 2421889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histologic markers in primary and metastatic tumors of the liver.
    Ganjei P; Nadji M; Albores-Saavedra J; Morales AR
    Cancer; 1988 Nov; 62(9):1994-8. PubMed ID: 2458825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variable antigen expression in hepatoblastomas.
    Ramsay AD; Bates AW; Williams S; Sebire NJ
    Appl Immunohistochem Mol Morphol; 2008 Mar; 16(2):140-7. PubMed ID: 18227729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatoblastoma: an immunohistochemical and ultrastructural study.
    Abenoza P; Manivel JC; Wick MR; Hagen K; Dehner LP
    Hum Pathol; 1987 Oct; 18(10):1025-35. PubMed ID: 2443437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improvement of dendritic-based vaccine efficacy against hepatitis B virus-related hepatocellular carcinoma by two tumor-associated antigen gene-infected dendritic cells.
    Yang JY; Cao DY; Xue Y; Yu ZC; Liu WC
    Hum Immunol; 2010 Mar; 71(3):255-62. PubMed ID: 20036295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemistry of germ cell and trophoblastic neoplasms.
    Niehans GA; Manivel JC; Copland GT; Scheithauer BW; Wick MR
    Cancer; 1988 Sep; 62(6):1113-23. PubMed ID: 2457424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of leukocyte migration inhibition by hepatitis B surface antigen in hepatocellular carcinoma patients.
    Lee CS; Chang KJ; Chen DS; Lin TY
    Zhonghua Min Guo Wei Sheng Wu Xue Za Zhi; 1979 Sep; 12(3):86-92. PubMed ID: 94850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatocellular carcinoma, adenoma, and focal nodular hyperplasia. Comparative histopathologic study with immunohistochemical parameters.
    Koelma IA; Nap M; Huitema S; Krom RA; Houthoff HJ
    Arch Pathol Lab Med; 1986 Nov; 110(11):1035-40. PubMed ID: 2430547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phenotypic characterization of hepatic proliferation. Antigenic expression by proliferating epithelial cells in fetal liver, massive hepatic necrosis, and nodular transformation of the liver.
    Gerber MA; Thung SN; Shen S; Stromeyer FW; Ishak KG
    Am J Pathol; 1983 Jan; 110(1):70-4. PubMed ID: 6185004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.